Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Jun 15;284(Pt 3):675–680. doi: 10.1042/bj2840675

Polyclonal antibody-catalysed amide hydrolysis.

G Gallacher 1, M Searcey 1, C S Jackson 1, K Brocklehurst 1
PMCID: PMC1132591  PMID: 1622388

Abstract

1. The activated amide (4-nitroanilide), N-(4-nitrophenyl) N'-butyl-1,4-phenylenediacetamide (III) was synthesized. 2. A polyclonal antibody preparation (PCA 270-29) was elicited in a multigeneration cross-bred sheep (no. 270) and isolated 29 weeks into the immunization schedule by procedures described previously for PCA 270-22 [Gallacher, Jackson, Searcey, Badman, Goel, Topham, Mellor & Brocklehurst (1991) Biochem J. 271, 871-881]. These involved the use of an amide conjugate bonded through the carboxy group of 4-nitrophenyl 4'-carboxymethylphenyl phosphate and an amino group of keyhole-limpet haemocyanin as the immunogen. 3. PCA 270-29 was shown to catalyse the hydrolysis of both the carbonate ester substrate 4-nitrophenyl 4'-(3-aza-2-oxoheptyl)phenyl carbonate (I) and the amide substrate (III). Both catalyses obeyed the Michaelis-Menten equation with the following values of the parameters at 25 degrees C: for the hydrolysis of (I) at pH 8.0, Km = 3.96 +/- 0.28 microM and k(cat.) = 0.135 +/- 0.004 s-1 (k(non-cat.) = 1.99 x 10(-4) s-1); for the hydrolysis of (III) at pH 9.0, Km = 5.4 +/- 1.4 microM and k(cat.) = (5.95 +/- 0.75) x 10(-5) s-1 (k(non-cat.) = approx. 2 x 10(-7) s-1). 4. The finding that PCA 270-29 is almost equally effective as a catalyst for the hydrolysis of the amide (III) as for that of the carbonate ester (I) when allowance is made for the different intrinsic reactivities of the two types of substrate is discussed. The catalytic characteristics of PCA 270-29, the first example of a polyclonal catalytic antibody preparation shown to catalyse the hydrolysis of an amide and the first example of an antibody preparation (monoclonal or polyclonal) with such catalytic character to be produced by use of a phosphate immunogen, are compared with those of the small number of other antibody-mediated hydrolyses of amides in the literature.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gallacher G., Jackson C. S., Searcey M., Badman G. T., Goel R., Topham C. M., Mellor G. W., Brocklehurst K. A polyclonal antibody preparation with Michaelian catalytic properties. Biochem J. 1991 Nov 1;279(Pt 3):871–881. doi: 10.1042/bj2790871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gallacher G., Jackson C. S., Topham C. M., Searcey M., Turner B. C., Badman G. T., Brocklehurst K. Polyclonal-antibody-catalysed hydrolysis of an aryl nitrophenyl carbonate. Biochem Soc Trans. 1990 Aug;18(4):600–601. doi: 10.1042/bst0180600. [DOI] [PubMed] [Google Scholar]
  3. Iverson B. L., Lerner R. A. Sequence-specific peptide cleavage catalyzed by an antibody. Science. 1989 Mar 3;243(4895):1184–1188. doi: 10.1126/science.2922606. [DOI] [PubMed] [Google Scholar]
  4. Janda K. D., Schloeder D., Benkovic S. J., Lerner R. A. Induction of an antibody that catalyzes the hydrolysis of an amide bond. Science. 1988 Sep 2;241(4870):1188–1191. doi: 10.1126/science.3413482. [DOI] [PubMed] [Google Scholar]
  5. Lerner R. A., Benkovic S. J., Schultz P. G. At the crossroads of chemistry and immunology: catalytic antibodies. Science. 1991 May 3;252(5006):659–667. doi: 10.1126/science.2024118. [DOI] [PubMed] [Google Scholar]
  6. Paul S., Volle D. J., Beach C. M., Johnson D. R., Powell M. J., Massey R. J. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science. 1989 Jun 9;244(4909):1158–1162. doi: 10.1126/science.2727702. [DOI] [PubMed] [Google Scholar]
  7. Pollack S. J., Jacobs J. W., Schultz P. G. Selective chemical catalysis by an antibody. Science. 1986 Dec 19;234(4783):1570–1573. doi: 10.1126/science.3787262. [DOI] [PubMed] [Google Scholar]
  8. Pollack S. J., Schultz P. G. Antibody catalysis by transition state stabilization. Cold Spring Harb Symp Quant Biol. 1987;52:97–104. doi: 10.1101/sqb.1987.052.01.014. [DOI] [PubMed] [Google Scholar]
  9. Raso V., Stollar B. D. The antibody-enzyme analogy. Comparison of enzymes and antibodies specific for phosphopyridoxyltyrosine. Biochemistry. 1975 Feb 11;14(3):591–599. doi: 10.1021/bi00674a020. [DOI] [PubMed] [Google Scholar]
  10. Thorsett E. D., Harris E. E., Peterson E. R., Greenlee W. J., Patchett A. A., Ulm E. H., Vassil T. C. Phosphorus-containing inhibitors of angiotensin-converting enzyme. Proc Natl Acad Sci U S A. 1982 Apr;79(7):2176–2180. doi: 10.1073/pnas.79.7.2176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tramontano A., Janda K. D., Lerner R. A. Catalytic antibodies. Science. 1986 Dec 19;234(4783):1566–1570. doi: 10.1126/science.3787261. [DOI] [PubMed] [Google Scholar]
  12. Wharton C. W., Cornish-Bowden A., Brocklehurst K., Crook E. M. Kinetics of the hydrolysis of N-benzoyl-L-serine methyl ester catalysed by bromelain and by papain. Analysis of modifier mechanisms by lattice nomography, computational methods of parameter evaluation for substrate-activated catalyses and consequences of postulated non-productive binding in bromelain- and papain-catalysed hydrolyses. Biochem J. 1974 Aug;141(2):365–381. doi: 10.1042/bj1410365. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES